[Frontiers in Bioscience 14, 1891-1901, January 1, 2009]

Cognitive and limbic effects of deep brain stimulation in preclinical studies

Yasin Temel1,3, Sonny Tan1,3, Rinske Vlamings1,3, Thibaut Sesia1,3, Lee Wei Lim1,3, Sylvie Lardeux2, Veerle Visser-Vandewalle1,3, Christelle Baunez2

1Departments of Neurosurgery and Neuroscience, Maastricht University, Maastricht, The Netherlands, 2Laboratoire de Neurobiologie de la Cognition, Centre National de la Recherche Scientifique, CNRS UMR6155 Aix-Marseille Université, Marseille, France, 3European Graduate School of Neuroscience (EURON), Maastricht, The Netherlands

TABLE OF CONTENTS

1. Abstract
2. Introduction
3. Historical considerations
4. Deep brain stimulation in animal models of movement disorders
4.1. Models of Parkinson's disease
4.2. Models of Huntington's disease
5. Deep brain stimulation in animal models of psychiatric disorders
5.1. Models of obsessive-compulsive disorder
5.2. Models of depression
5.3. Models of anxiety disorders
6. Discussion
7. Perspective
8. Acknowledgements
9. References

1. ABSTRACT

The use of deep brain stimulation (DBS) to control severely disabling neurological and psychiatric conditions is an exciting and fast emerging area of neuroscience. Deep brain stimulation has generally the same clinical effects as a lesion with respect to the improvement of clinical disability, but has more advantages such as its adjustability and reversibility. To this day, fundamental knowledge regarding the application of electrical currents to deep brain structures is far from complete. Despite improving key symptoms in movement disorders, DBS can be associated with the occurrence of a variety of changes in cognitive and limbic functions both in humans and animals. Furthermore, in psychiatric disorders, DBS is primarily used to evoke cognitive and limbic changes to reduce the psychiatric disability. Preclinical DBS experiments have been carried out to investigate the mechanisms underlying the clinical effects of DBS for at least three (interrelated) reasons: to increase our scientific knowledge, to optimize/refine the technology, or to prevent/reduce side-effects. In this review, we will discuss the limbic and cognitive effects of DBS in preclinical studies.